Billionaire Dan Loeb Sold Third Point's Entire Stake in Alphabet in Favor of One of Wall Street's Priciest (and High-Flying) Artificial Intelligence (AI) Stocks
Dan Loeb is swapping out one of the cheapest industry-leading AI stocks for another with well-defined competitive advantages and a nosebleed valuation.
Alphabet Uses AI To Rush First Responders To Wildfires — Takeaways For Businesses
An initiative from Google’s parent company that rushes the National Guard to climate disasters stands ready to review aerial images from the LA wildfires.
Ex-Google, Meta Execs Building Emotionally Aware AI Sales Agents
Three former engineering leaders from Alphabet Inc.’s Google, Meta Platforms Inc. and Samsung Electronics Co. have raised $10 million for a new startup focused on making artificial ...
Why Alphabet Stock Popped Today
Alphabet ( GOOG 1.63%) ( GOOGL 1.58%) stock got a small lift on Tuesday, rising 2% higher through 10:30 a.m. ET. The move ...
The Best AI Stocks to Invest $500 in This Year
Artificial intelligence (AI) was a market-driving theme last year, with AI stocks helping the S&P 500, the Nasdaq, and the ...
Alphabet’s Resilience and Strategic AI Transition: Buy Rating Affirmed
Analyst Justin Post of Bank of America Securities maintained a Buy rating on Alphabet Class A (GOOGL – Research Report), retaining the price ...
Where Will Alphabet Stock Be in 1 Year?
CEO Sundar Pichai described current trends as "extraordinary," projecting confidence in the company's forward outlook. Wall ...
Why Is Prem Watsa Bullish On Alphabet Inc. (GOOGL) Now?
Prem Watsa is a Canadian billionaire, entrepreneur, and investor often referred to as the Canadian Warren Buffett for his ...
Google-backed, AI-developed drugs are headed to trial by 2026, DeepMind CEO says
Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.